This information is for educational purposes only
Learn more about the GHK-Cu peptide here
Patients with pre-existing gastrointestinal conditions, such as peptic ulcer disease or gastro-oesophageal reflux disease (GORD), should exercise particular caution
Up to approximately 2 months after the last instillation, significant improvement in OSSI and OSPI scores, pain VAS, voided volumes, frequency, and nocturia also were reported
These early benefits reflect the anti-inflammatory properties of both peptides rather than structural tissue repair, which requires longer timeframes
Metabolic Research Applications: Studied in models of obesity, diabetes, and age-related metabolic decline